Showing results (351-360 of 382) with videos related to

Sort By:
Pageof 39
Alimentary Pharmacology & Therapeutics|April 19, 2007
Sustained virological response to interferon reduces cirrhosis in chronic hepatitis C: a 1,386-patient study from TaiwanJ-F Huang, M-L Yu, C-M Lee, et al.
Journal of Viral Hepatitis|November 22, 2014
Alisporivir with peginterferon/ribavirin in patients with chronic hepatitis C genotype 1 infection who failed to respond to or relapsed after prior interferon-based therapy: FUNDAMENTAL, a Phase II trialM Buti, R Flisiak, J-H Kao, et al.
Journal of Medical Virology|August 16, 2001
Changing prevalence of hepatitis C virus genotypes: molecular epidemiology and clinical implications in the hepatitis C virus hyperendemic areas and a tertiary referral center in TaiwanM L Yu, W L Chuang, S C Chen, et al.
The Kaohsiung Journal of Medical Sciences|March 29, 2001
The epidemiology of TT virus (TTV) infection in a hepatitis C and B virus hyperendemic area of southern TaiwanC Y Dai, M L Yu, W L Chuang, et al.
The Journal of Biological Chemistry|December 21, 2013
Structure-guided development of specific pyruvate dehydrogenase kinase inhibitors targeting the ATP-binding pocketShih-Chia Tso, Xiangbing Qi, Wen-Jun Gui, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 15, 2024
Clinical outcomes and predictors of transapical transcatheter mitral valve replacement: the Tendyne Expanded Clinical StudyLenard Conradi, Sebastian Ludwig, Paul Sorajja, et al.
Light, Science & Applications|January 29, 2026
Collection of fluorescence from an ion using trap-integrated photonicsFelix W Knollmann, Sabrina M Corsetti, Ethan R Clements, et al.
International Journal of Obesity (2005)|September 16, 2009
Abnormal liver function test results are related to metabolic syndrome and BMI in Taiwanese adults without chronic hepatitis B or CM-H Hsieh, C-K Ho, N-J Hou, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|March 9, 2004
Serum insulin-like growth factor-II and alpha-fetoprotein as tumor markers of hepatocellular carcinomaJ F Tsai, J E Jeng, L Y Chuang, et al.
Alimentary Pharmacology & Therapeutics|March 10, 2018
Responses are durable for up to 5 years after completion of peginterferon alfa-2a treatment in hepatitis B e antigen-positive patientsW-L Chuang, J Jia, H L Y Chan, et al.
Pageof 39